Biogenic and biomimetic nanocarrier-based interventions: focus on intracellular infections

Nanomedicine (Lond). 2021 Apr;16(9):685-688. doi: 10.2217/nnm-2021-0052. Epub 2021 Mar 8.

Authors

Jiří Trousil¹, Santosh Aryal², Gregor Fuhrmann³

Affiliations

¹ Institute of Macromolecular Chemistry, Czech Academy of Sciences, Prague, 16200, Czech Republic.
² Department of Chemistry, Nanotechnology Innovation Center of Kansas State (NICKS), Kansas State University, Manhattan, KS 66506, USA.
³ Helmholtz Centre for Infection Research (HZI), Biogenic Nanotherapeutics Group (BION), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Saarbrücken, 66123, Germany.

PMID: 33683144
DOI: 10.2217/nnm-2021-0052

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Biomimetics*
Drug Carriers*
Drug Delivery Systems

Substances

Drug Carriers

Grants and funding